The novel approach of the medication represents a exciting advance in the care of type 2 diabetes. Distinct from existing medications, tirzepatide targets two pathways – GLP-1 and the GIP hormone – resulting in https://tirzepatidepeptide982503.blogaritma.com/39840979/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment